Literature DB >> 8382006

Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2.

A A Nanji1, U Khettry, S M Sadrzadeh, T Yamanaka.   

Abstract

The purpose of our study is to determine if a relationship exists between the severity of injury in experimental alcoholic liver disease and plasma levels of endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Four groups of animals (n = 4 to 8 in each group) were fed a liquid diet with corn oil (25% of calories) and ethanol over various time periods: 1 week, 2 weeks, 1 month, and 2 months. At sacrifice, liver pathology scores and plasma levels of the above were determined. Plasma levels of endotoxin were already increased after 1 week (26.6 +/- 18.6 pg/ml) and continued to increase over time, with the highest levels at 2 months (69.5 +/- 24.5 pg/ml). A strong positive correlation (r = 0.84, P < 0.001) was seen between plasma endotoxin levels and severity of liver injury. The pathology score also correlated positively with leukotriene B4 (r = 0.47, P < 0.05) and thromboxane B2 (0.66, P < 0.01). A negative correlation was obtained with prostaglandin E2 levels (r = -0.44, P < 0.05). A positive correlation was also seen between endotoxin levels and leukotriene B4 (r = 0.57, P < 0.02) and thromboxane B2 (0.64, P < 0.01); a negative correlation was obtained with prostaglandin E2 levels (r = -0.55, P < 0.02). Each metabolite was also correlated with each of the features of alcoholic liver injury, i.e., fatty liver, necrosis, and inflammation. With prostaglandin E2, the most marked decrease was seen in association with severe fatty liver (3 to 4+). Thromboxane B2 correlated best with presence of inflammation and necrosis. Our study shows the importance of endotoxin in the pathogenesis of experimental alcoholic liver disease and suggests that endotoxin modulates production of eicosanoids that contribute to the severity of liver injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382006      PMCID: PMC1886727     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Prevention of thromboxane B2-induced hepatocyte plasma membrane bleb formation by certain prostaglandins and a proteinase inhibitor.

Authors:  A A Horton; J M Wood
Journal:  Biochim Biophys Acta       Date:  1990-03

2.  Endotoxin hepatotoxicity augmented by ethanol.

Authors:  Y Shibayama; S Asaka; K Nakata
Journal:  Exp Mol Pathol       Date:  1991-10       Impact factor: 3.362

3.  Endotoxin-induced hypercoagulability: a possible aggravating factor of alcoholic liver disease.

Authors:  M Arai; S Nakano; F Okuno; Y Hirano; K Sujita; T Kobayashi; H Ishii; M Tsuchiya
Journal:  Hepatology       Date:  1989-06       Impact factor: 17.425

4.  Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1.

Authors:  G Goldman; R Welbourn; J M Klausner; C R Valeri; D Shepro; H B Hechtman
Journal:  Circ Res       Date:  1991-04       Impact factor: 17.367

5.  Alcohol induced depression of reticuloendothelial function in the rat.

Authors:  M V Ali; J P Nolan
Journal:  J Lab Clin Med       Date:  1967-08

Review 6.  Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report.

Authors:  H Tsukamoto; K Gaal; S W French
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

7.  Degradation of arachidonyl phospholipids catalyzed by two phospholipases A2 and phospholipase C in a lipopolysaccharide-treated macrophage cell line RAW264.7.

Authors:  Y Tanaka; F Amano; H Kishi; M Nishijima; Y Akamatsu
Journal:  Arch Biochem Biophys       Date:  1989-07       Impact factor: 4.013

8.  Eicosanoid production in nonparenchymal liver cells isolated from rats infused with E. coli endotoxin.

Authors:  E B Rodriguez de Turco; J A Spitzer
Journal:  J Leukoc Biol       Date:  1990-12       Impact factor: 4.962

9.  Protection by 16,16-dimethyl prostaglandin E2 and dibutyryl cyclic AMP against complement-mediated hepatic necrosis in rats.

Authors:  Y Kurebayashi; Y Honda
Journal:  Hepatology       Date:  1991-09       Impact factor: 17.425

10.  Beef fat prevents alcoholic liver disease in the rat.

Authors:  A A Nanji; C L Mendenhall; S W French
Journal:  Alcohol Clin Exp Res       Date:  1989-02       Impact factor: 3.455

View more
  73 in total

1.  Colonic microbiome is altered in alcoholism.

Authors:  Ece A Mutlu; Patrick M Gillevet; Huzefa Rangwala; Masoumeh Sikaroodi; Ammar Naqvi; Phillip A Engen; Mary Kwasny; Cynthia K Lau; Ali Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-12       Impact factor: 4.052

Review 2.  Alcoholic liver disease: the gut microbiome and liver cross talk.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Bernd Schnabl
Journal:  Alcohol Clin Exp Res       Date:  2015-05       Impact factor: 3.455

Review 3.  Gut flora and bacterial translocation in chronic liver disease.

Authors:  John Almeida; Sumedha Galhenage; Jennifer Yu; Jelica Kurtovic; Stephen M Riordan
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

4.  Comparison of rat liver and brain proteasomes for oxidative stress-induced inactivation: Influence of ageing and dietary restriction.

Authors:  Kalavathi Dasuri; Anhthao Nguyen; Le Zhang; Ok Sun Fernandez-Kim; Annadora J Bruce-Keller; Bradford A Blalock; Rafael De Cabo; Jeffrey N Keller
Journal:  Free Radic Res       Date:  2009-01

5.  Eicosanoid production in experimental alcoholic liver disease is related to vitamin E levels and lipid peroxidation.

Authors:  A A Nanji; S Khwaja; S M Sadrzadeh
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

6.  Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators.

Authors:  Brian T Kalish; Hau D Le; Jonathan M Fitzgerald; Samantha Wang; Kyle Seamon; Kathleen M Gura; Karsten Gronert; Mark Puder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-03       Impact factor: 4.052

Review 7.  Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease.

Authors:  Courtney S Schaffert; Michael J Duryee; Carlos D Hunter; Bartlett C Hamilton; Amy L DeVeney; Mary M Huerter; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

8.  Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol.

Authors:  Irina A Kirpich; Wenke Feng; Yuhua Wang; Yanlong Liu; Juliane I Beier; Gavin E Arteel; K Cameron Falkner; Shirish S Barve; Craig J McClain
Journal:  Alcohol       Date:  2013-02-26       Impact factor: 2.405

Review 9.  Alcohol and lipid metabolism.

Authors:  Margaret Sozio; David W Crabb
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-18       Impact factor: 4.310

10.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.

Authors:  P D Cani; S Possemiers; T Van de Wiele; Y Guiot; A Everard; O Rottier; L Geurts; D Naslain; A Neyrinck; D M Lambert; G G Muccioli; N M Delzenne
Journal:  Gut       Date:  2009-02-24       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.